In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients
Journal article published in 2012 by
H. de Jonge,
H. de Loor 
,
K. Verbeke,
Y. Vanrenterghem,
D. R. Kuypers
,
K. Verbeke,
Y. Vanrenterghem,
D. R. Kuypers
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 